← Eichor
Study identifier: NCT05913427 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)

Condition: Adrenocortical Carcinoma  ·  Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

PhasePhase 2
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective randomized, double blind, placebo controlled phase II study planned in patients with advanced ACC. The study will be conducted at ASST Spedali Civili Hospital and University of Brescia in Brescia.

This description comes directly from the study's public registry record.

Talk to the study team

Aldo Roccaro  ·  +390303996851  ·  coordinamento.ricerca@asst-spedalicivili.it

Always discuss trial participation with your own doctor first.

Locations (1)

Alfredo BerrutiBrescia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05913427